SCHEMBL17829232

SCHEMBL17829232

CCCCOc1c2n(cc(C(=O)NCc3ccc(F)cc3F)c1=O)C1(CCOCC1)CN(CCOC)C2=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829241 0.93
SCHEMBL17829142 0.93
SCHEMBL17829148 0.92
SCHEMBL19625197 0.90
SCHEMBL17829064 0.89
SCHEMBL17829228 0.87
SCHEMBL17829467 0.87
SCHEMBL17828671 0.84
SCHEMBL16846898 0.84 SLC22A2 (0.45)
SCHEMBL16847249 0.84 SLC22A2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334924-A1 Spirocyclic Heterocyclic Compounds Useful As HIV Integrase Inhibitors MERCK SHARP & DOHME CORP. (US) 2017-11-23 US disclosed
WO-2016094197-A1 SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-06-16 WO disclosed
WO-2016090545-A1 SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRATE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-06-16 WO disclosed